SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001498376-10-000003
Filing Date
2010-11-02
Accepted
2010-11-02 14:09:47
Documents
2
Period of Report
2010-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3912
2 POA poababiss.txt EX-24 3480
  Complete submission text file 0001498376-10-000003.txt   9154
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115
Business Address
Babiss Lee (Reporting) CIK: 0001498376 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27570 | Film No.: 101157564